Fundraising Fox

Highfield Diagnostics

1 known investors

Highfield Diagnostics develops point-of-care diagnostic tests using laser-patterned paper substrates that can detect multiple conditions in a single rapid, portable test. The technology targets patients self-monitoring chronic conditions, healthcare providers and rapid-response settings, with additional applications in veterinary medicine, water utilities, and the food and beverage industry.

Investors · 1

Companies House · registry record

View on Companies House ↗
Registered name
HIGHFIELD DIAGNOSTICS LTD
Company number
11071121
Status
Active
Company type
Private limited company
Incorporated
20 Nov 2017
Registered office
White Building Studios, 1-4 Cumberland Place, Southampton, Hampshire, SO15 2NP
Nature of business (SIC)
32500 — Manufacture of medical and dental instruments and supplies
Accounts
last made up to 30 Nov 2025 · next due 31 Aug 2027
Confirmation statement
last made up to 1 May 2026 · next due 15 May 2027

Current officers · 2

  • Robert William Eason director, appointed 20 Nov 2017
  • Zhiyuan Zhu director, appointed 15 Apr 2021

Source: Companies House public register · retrieved 23 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.

In the news

Frequently asked questions

What does Highfield Diagnostics do?
Highfield Diagnostics develops point-of-care diagnostic tests using laser-patterned paper substrates that can detect multiple conditions in a single rapid, portable test. The technology targets patients self-monitoring chronic conditions, healthcare providers and rapid-response settings, with additional applications in veterinary medicine, water utilities, and the food and beverage industry.
Who are Highfield Diagnostics's investors?
Highfield Diagnostics's investors include Verge HealthTech Fund.